Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Comparison of extramedullary plasmacytome vs. EMD finds EMP has shared several genetic features but lower complexity and is enriched for TRAF3 mutations, while EMD has more NRAS/KRAS, TP53, TENT5C, ARID1A and ATM mutations.”
Title: The genetic landscape of extramedullary plasmacytoma: a comparative analysis with extramedullary disease of multiple myeloma
Authors: Antonio Vogelsberg, Julia Salmerón-Villalobos, Anna-Lisa Wilhelmi, Franziska Otto, Aylin Schneider, Barbara Mankel, Eyyub Bag, Ariadna Colmenero, Matthias S. Dettmer, Marina Narbaitz, Alexandar Tzankov, Itziar Salaverria, Irina Bonzheim, Falko Fend
You can read the Full Article in Haematologica.
You can find other articles featuring Robert Orlowski on OncoDaily.
